• Excellence

    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.

  • National

    The CCCTG is a national organization of more than 350 individuals with research interests in the management of the critically ill patient.

  • Clinical

    The CCCTG has more than 75 research programs underway and over 260 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.

  • Impact

    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous & ethical manner, and communicated in a timely & effective way to maximise impact.

  • Direction

    Leading Science, Saving Lives — 5-year Strategic Plan to further enhance the impact of the CCCTG in Canada and around the world.

  • Research

    The Canadian Critical Care Translational Biology Group (CCCTBG) is a collegial group that is dedicated to the pursuit of excellence and promotion of translational research related to critical care conditions.

  • Focus on
    Diversity in Critical Care Medicine is Important!

    Equity, diversity, and inclusion are core values of the CCCTG. Diversity in life experiences and backgrounds provide diversity of thought. Diversity of thought leads to the best science. It is important to represent the gender, cultural, and ethnic diversity of the critical care community to ensure representativeness, provide role models, and foster a critical care community based on inclusivity.  Click Learn More to read CCCTG's policy.

  • Focus on
    Research Chair in Pandemic Preparedness Research

    The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) announces that Dr. Srinivas Murthy has been awarded the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research.

  • Focus on
    Innovative adaptive trial design to evaluate multiple treatment options simultaneously

    REMAP-CAP uses a novel and innovative trial design able to adapt in the event of pandemics, and increases the likelihood that patients will receive the treatment that is most likely to be effective for them. REMAP-CAP is currently enrollling COVID-19 patients. Click on Learn More to get to the trial website.

  • Focus on
    Canadian Treatments for COVID-19

    In conjunction with the World Health Organization, Canada is participating in the SOLIDARITY trial, a global platform of research that is in various stages of approval in over 90 countries. 

  • Focus on
    The LOVIT Trial: Lessening Organ dysfunction with VITamin C

    Recent preliminary evidence suggests that intravenous vitamin C may be the first therapy to mitigate the dysregulated cascade of events transforming an infection into sepsis. However, definitive practice changing evidence requires a large trial powered to detect a plausible, modest, and clinically important difference in mortality. Click on Learn More to learn more about LOVIT.

  • Focus on
    Rapid research response to contribute to global efforts to contain the Coronavirus outbreak

    The CIHR supports Drs. Jeanna Parsons Leigh and Srinivas Murthy through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity.

  • Focus on
    Gender differences in funding rates

    Study reveals gender disparity exists in grant and personnel award success rates, especially for grants directed to selected research communities. This information is important to address potential sources of bias in the review process. Click Learn More to read the full article.

  • Focus on
    Statement from CIHR supporting critical care research

    Dr. Brian Rowe acknowledges the role of research in critical care medicine and recognize the excellent work of health care professionals who provide intensive care. He also mentions contribution and impact of the CCCTG.

  • Focus on
    A global collaboration of acute care clinical researchers

    InFACT members include three dozen investigator-led research consortia from around the world. These groups have conducted many of the most impactful clinical trials in critical care. This year marks the 10th Anniversary of InFACT.

  • Focus on
    CCCTG launches new website for patients and families

    The CCCTG Patient and Family Engagement Committee has just launched the new website for patients and families who are experiencing, or have experienced, critical care. The purpose of the website is to support and engage patients and families in research.

  • Focus on
    The CCCTG awards two research fellowships

    The CCCTG is thrilled to support Drs. Nadia Roumeliotis and Oleksa Rewa so they can add to their experience by engaging in critical care research.  We are thankful to our partners, Fonds de recherche santé Québec and Alberta Health Services through the Critical Care Strategic Clinical Network for their contributions to the CCCTG Fellowship Program.

  • Focus on
    Following the patients and families after critical illness

    The RECOVER Program, lead by Dr. Margaret Herridge aims to elucidate the impact of critical illness and the caregiving situation on patients' and caregivers' long-term physical function and mental health.

  • Focus on
    Care in Canadian ICUs

    The CCCTG contributes to the development of the report from the Canadian Institute of Health Information (CIHI) about the care in Canadian intensive care units. Click Learn More to access CIHI's report.

  • Focus on
    Prediction of neurological outcomes following severe traumatic brain injury

    The TBI-Prognosis study aims at developing a prediction model to help provide objective information to patients and families on long-term prognosis in critically ill patients with severe traumatic brain injury. This multicenter prospective study is conducted by Dr Alexis Turgeon and a team of colleagues in 17 centers across Canada. Enrolment in the study has just been completed and 12-month follow-up outcome measures are ongoing.

  • Focus on
    Optimal use of vasopressors in patients suffering from vasodilatory shock

    François Lamontagne and the OVATION team have published the results from the pilot sutdy.  Click Learn More to view a video from Dr. Lamontagne and colleagues explaining the trial and the use of vasopressors in critically ill patients.

  • Focus on
    Renal replacement therapy in the critically ill – early the better?

    Acute kidney injury (AKI) is a common and increasingly encountered complication of critical illness. The STARRT-AKI research program aims to investigate strategies to starting acute renal replacement therapy in critically ill patients with severe AKI.

  • Focus on
    Value of investigator-led clinical trials

    Researchers from the CCCTG investigated factors influencing the impact of clinical trials.  Authors found that investigator-lead clinical trials increasingly shape the knowledge base of critical care, in particular trials led by investigators within structured critical care research consortia.  Click Learn More to read the full article.

  • Focus on
    The importance of Vitamin D in critically ill children

    Dr. Dayre McNally, physician in CHEO’s pediatric intensive care unit, investigates how optimizing Vitamin D levels can help treat critically ill children. Click Learn More to view Dr. McNally's video.

  • Focus on
    Can we better predict extubation outcomes?

    Prolonged mechanical ventilation and failed extubation harm patients. The WAVE score is able to predict extubation failures better than simple vitals, clinical impression and commonly used indices, in particular in patients perceived as high-risk.

  • Focus on
    Sedation management in the critically ill

    All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications. Researchers from the CCCTG compared sedation strategies in critically ill mechanically ventilated patients.

  • Focus on
    How to define death?

    Article in Critical Care Medicine showed that it is feasible and acceptable to study the natural history of death after withdrawal of life sustaining therapy in the ICU.  The DePPaRT study aims to aims to provide much needed information to provide guidance to "donation after circulatory death (DCD)" practice.

  • Focus on
    Outcome and Research Priorities in Intensive Care Studies (OPTICS)

    The OPTICS research program lead by Drs. John Muscedere and François Lamontagne aims to understand differences in priorities between patients, citizens, decision-makers and researchers about research priorities and outcomes assessment in critical care clinical research.  Click on Learn More for a short video (in French only) presenting the OPTICS study.

  • Focus on
    Old blood as good as fresh blood in critically ill patients

    Blood used for transfusions is perishable. But contrary to general belief, results from a new study from CCCTG researchers published today in the New England Journal of Medicine shows that blood stored for three weeks is just as good as fresh blood.

  • Focus on
    Better treatment strategies for critically ill patients and the potential impact for the healthcare system

    The results of the PROTECT Trial and the recent corresponding cost-effectiveness study showed better health outcomes and overall, lower health care costs when using low molecular weight heparin dalteparin for the prevention of venous thromboembolism in the ICU.

  • Dr. Meade

    Dr. Maureen Meade - 2020 CIHR‑ICRH/CCCS Distinguished Lecturer Award in Critical Care Sciences

  • CCCTG Grant

    Request for applications for the CCCTG Early Career Research Grant 2020.  The submission deadline is September 21, 2020 at 5pm EDT.

  • CCCTG Meeting

    The CCCTG Fall 2020 Scientific Meeting goes Virtual and will be held October 8, 2020.

  • CCCTBG Meeting

    The CCCTBG Spring 2020 Scientific Meeting goes virtual and will be held June 8, 2020.

  • ICU Data

    Request for "Ideas" for CCCTG Data Initiatives Supporting Critical Care Research and Quality Improvement.  The submission deadline is August 30, 2019 at 5pm EDT.

  • Dr. Lacroix

    Dr. Jacques Lacroix – Recipient: 2019 CIHR‑ICRH/CCCS Distinguished Lecturer Award in Critical Care Sciences

  • 2018 Annual Report

    We are pleased to announce the CCCTG 2017-2018 Annual Activity Report is now available. Click Learn More to access it.

  • Dr. Cook

    Congratulations to Deborah Cook for being chosen a recipient of the 2018 CIHR Gold Leaf Award. 

  • CCCF 2019

    The Critical Care Canada Forum 2019 will be held in Toronto ON, November 10-13, 2019.

  • Code of Conduct

    The CCCTG is adopting a Code of Conduct Policy.

  • Diversity Policy

    The CCCTG is adopting a policy to support diversity in its governance and sponsored activities.

  • Dr. Marshall

    Dr. John Marshall – Recipient: 2018 CIHR‑ICRH/CCCS Distinguished Lecturer Award in Critical Care Sciences

  • World Sepsis

    World Sepsis Day is on September 13, 2018.  Support this initiative led by the Global Sepsis Alliance.

  • Dr. Stelfox

    In recognition to his exceptional contributions to the promotion of critical care research through mentorship, Dr. Henry T. Stelfox receives the 2017 Deborah J. Cook Mentorship Award.

  • Dr. Turgeon

    Alexis Turgeon receives a Canada Research Chair in Critical Care Neurology and Trauma 

  • Dr. Pagliarello

    Dr. Giuseppe Pagliarello receives lifetime achievement award in organ donation from Trillium Gift of Life Network.

  • Dr. Menon

    Kusum Menon receives a Tier 2 Research Chair in Pediatric Shock from the University of Ottawa!